Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.

× No keyword cloud information.

6 in total

Review 1. Second-line treatment of metastatic prostatic carcinoma.

Authors: D W Newling
Journal: Urol Res Date: 1997

Review 2. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors: G L Plosker; D Faulds
Journal: Drugs Date: 1993-05 Impact factor: 9.546

3. The use of adriamycin and its derivatives in the treatment of prostatic cancer.

Authors: D W Newling
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

4. A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.

Authors: G van Andel; P Fernandez de Moral; C T M Caris; P Carpentier; J Wils; M J F M de Bruin; J A Witjes; F M J Debruyne; W P J Witjes
Journal: World J Urol Date: 2003-06-18 Impact factor: 4.226

5. Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer.

Authors: H Fuse; Y Muraishi; Y Fujishiro; T Katayama
Journal: Int Urol Nephrol Date: 1996 Impact factor: 2.370

6. Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.

Authors: E H Hernes; S D Fosså; S Vaage; P Ogreid; A Heilo; E Paus
Journal: Br J Cancer Date: 1997 Impact factor: 7.640

6 in total